DE602004020619D1 - EXPRESSIONSSYSTEM FÜR siRNA - Google Patents

EXPRESSIONSSYSTEM FÜR siRNA

Info

Publication number
DE602004020619D1
DE602004020619D1 DE602004020619T DE602004020619T DE602004020619D1 DE 602004020619 D1 DE602004020619 D1 DE 602004020619D1 DE 602004020619 T DE602004020619 T DE 602004020619T DE 602004020619 T DE602004020619 T DE 602004020619T DE 602004020619 D1 DE602004020619 D1 DE 602004020619D1
Authority
DE
Germany
Prior art keywords
sirna
expression system
downstream
rna
gene
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE602004020619T
Other languages
English (en)
Inventor
Irene Bozzoni
Michela A Denti
Alessandro Rosa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of DE602004020619D1 publication Critical patent/DE602004020619D1/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/11DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C12N15/113Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2310/00Structure or type of the nucleic acid
    • C12N2310/10Type of nucleic acid
    • C12N2310/11Antisense
    • C12N2310/111Antisense spanning the whole gene, or a large part of it
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2310/00Structure or type of the nucleic acid
    • C12N2310/10Type of nucleic acid
    • C12N2310/14Type of nucleic acid interfering N.A.
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2330/00Production
    • C12N2330/30Production chemically synthesised

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Biomedical Technology (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Zoology (AREA)
  • Molecular Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biophysics (AREA)
  • Microbiology (AREA)
  • Plant Pathology (AREA)
  • Biochemistry (AREA)
  • Physics & Mathematics (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Steroid Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Compounds Of Unknown Constitution (AREA)
  • Oscillators With Electromechanical Resonators (AREA)
  • Saccharide Compounds (AREA)
DE602004020619T 2003-07-09 2004-07-09 EXPRESSIONSSYSTEM FÜR siRNA Expired - Lifetime DE602004020619D1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IT000335A ITRM20030335A1 (it) 2003-07-09 2003-07-09 Sistema di espressione di sirna.
PCT/IT2004/000381 WO2005005634A2 (en) 2003-07-09 2004-07-09 siRNA EXPRESSION SYSTEM

Publications (1)

Publication Number Publication Date
DE602004020619D1 true DE602004020619D1 (de) 2009-05-28

Family

ID=29765906

Family Applications (1)

Application Number Title Priority Date Filing Date
DE602004020619T Expired - Lifetime DE602004020619D1 (de) 2003-07-09 2004-07-09 EXPRESSIONSSYSTEM FÜR siRNA

Country Status (10)

Country Link
US (1) US7947823B2 (de)
EP (1) EP1644499B1 (de)
JP (1) JP4762897B2 (de)
CN (1) CN1820074A (de)
AT (1) ATE428783T1 (de)
AU (1) AU2004256322B2 (de)
CA (1) CA2532019A1 (de)
DE (1) DE602004020619D1 (de)
IT (1) ITRM20030335A1 (de)
WO (1) WO2005005634A2 (de)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20060040391A1 (en) * 2004-08-20 2006-02-23 Promega Corporation RNA interference vectors
CN100357436C (zh) * 2005-07-01 2007-12-26 中国人民解放军第三军医大学 抑制Stat3基因表达的siRNA及其制备方法
EP2666865A3 (de) * 2007-01-18 2014-02-19 Plant Bioscience Limited (PBL) Verfahren und Zusammensetzungen zum Modulieren des miRNA-Pfads
CN109486813B (zh) * 2018-10-10 2022-01-18 广州医科大学附属第二医院 一种用于修复TPP1基因Pre-mRNA异常剪接的U1-snRNA及其应用

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6013447A (en) * 1997-11-21 2000-01-11 Innovir Laboratories, Inc. Random intracellular method for obtaining optimally active nucleic acid molecules
DE10100586C1 (de) * 2001-01-09 2002-04-11 Ribopharma Ag Verfahren zur Hemmung der Expression eines Ziegens

Also Published As

Publication number Publication date
EP1644499B1 (de) 2009-04-15
WO2005005634A2 (en) 2005-01-20
ATE428783T1 (de) 2009-05-15
WO2005005634A3 (en) 2005-02-24
AU2004256322A1 (en) 2005-01-20
CN1820074A (zh) 2006-08-16
JP2007518393A (ja) 2007-07-12
AU2004256322B2 (en) 2009-11-12
JP4762897B2 (ja) 2011-08-31
ITRM20030335A1 (it) 2005-01-10
EP1644499A2 (de) 2006-04-12
ITRM20030335A0 (it) 2003-07-09
US20060217327A1 (en) 2006-09-28
US7947823B2 (en) 2011-05-24
CA2532019A1 (en) 2005-01-20

Similar Documents

Publication Publication Date Title
Maier et al. Replication by a single DNA polymerase of a stretched single-stranded DNA
EP1750771A4 (de) Pankreasinsel-mikro-rna und verfahren zu ihrer unterdrückung
WO2004013280A3 (en) ALLELE-SPECIFIC siRNA-MEDIATED GENE SILENCING
WO2006135436A3 (en) Inhibition of gene expression and therapeutic uses thereof
EP2305812A3 (de) Funktionale und hyperfunktionale siRNA
WO2006031901A3 (en) SMALL INTERFERING RNAs THAT EFFICIENTLY INHIBIT VIRAL GENE EXPRESSION AND METHODS OF USE THEREOF
ZA202212490B (en) Inhibition of unintended mutations in gene editing
NO20070263L (no) Immunostimulerende oligonukleotidmultimerer
ATE443133T1 (de) Oligonukleotidzusammensetzungen mit verbesserter effizienz
WO2006066048A3 (en) Compositions for bacterial mediated gene silencing and methods of using same
DK1476562T3 (da) Overekspression af extremozymgener i pseudomonas og nært beslægtede bakterier
DK1309726T3 (da) RNA-sekvensspecifikke formidlere af RNA-interferens
WO2004065613A3 (en) Inducible small interfering rna (sirna) expression constructs for targeted gene silencing
WO2001025488A3 (en) Method for enrichment of natural antisense messenger rna
DE60237542D1 (de) Ein system zur stabilen expression von sirnas in säugetierzellen
EP1556402A4 (de) Abstellen von genen in vivo durch chemischmodifizierte und stabile sirna
ATE514783T1 (de) Plasmidsystem zur expression mehrerer gene
WO2005078094A3 (en) Stabilized rnas as transfection controls and silencing reagents
WO2008028661A3 (en) Potexvirus- derived replicon
Cressey et al. Mechanism for de novo initiation at two sites in the respiratory syncytial virus promoter
DK1412505T3 (da) DNA-sekvenser til regulering af transkription
ATE548454T1 (de) Nukleinsäurewirkstoffe zur stilllegung von h19 zwecks behandlung rheumatoider arthritis
WO2019140116A3 (en) Amplifiable rnas for therapeutic cell systems
EP1841871A4 (de) Neuer l-lysin-induzierbarer promotor
Kolb et al. Hexitol nucleic acid-containing aptamers are efficient ligands of HIV-1 TAR RNA

Legal Events

Date Code Title Description
8364 No opposition during term of opposition